Alerts

• NEW: The Physician Assistant Board (Board) would like to notify you that the Cybersecurity & Infrastructure Security Agency, Federal Bureau of Investigation, and the Department of Health and Human Services have credible information of an increased and imminent cybercrime threat to U.S. hospitals and healthcare providers. The Board is sharing this information to provide warning to healthcare providers to ensure that they take timely and reasonable precautions to protect their networks from these threats. Please see additional information at the Cybersecurity & Infrastructure Security Agency website: https://us-cert.cisa.gov/ncas/alerts/aa20-302a.
• NEW: Updated Prescription Pad Security Requirements
  Starting January 1, 2021, pads used to write and fill prescriptions for controlled substances are required to have a 12-character serial number, a corresponding barcode, and other security features required by Assembly Bill 149.
  California-approved security printers have been issuing these prescription pads since the beginning of 2020. Starting January 1, 2021, except for limited emergency situations, pharmacists will be unable to fill a controlled substance prescription that is not on a compliant form.
  Prescribers who do not possess these prescription pads are encouraged to place an order as soon as possible from a Security Prescription Printer approved by the Department of Justice. Doing so will help ensure you receive compliant prescription pads in a timely manner.
  Prescriptions issued electronically are not subject to the security features related to paper forms.
  
• Department of Consumer Affairs Waivers
• NEW: DCA Waiver DCA-20-69 Waiver Further Extending Division 2 CE and Exam Renewal Requirements
• NEW: DCA Waiver DCA-20-67 Waiver Extending Physician Assistant, Nurse Practitioner, and Nurse-Midwife Supervision By 60 Days
• NEW: DCA Waiver DCA-20-57 Reinstatement of Licensure
• NEW: DCA Waiver DCA-20-53 Waiving License Renewal Requirements - Note: Superseded with DCA Waiver 20-69
• Order Extending Three April 14, 2020, Orders Relating to Physician Assistant, Nurse Practitioner, and Nurse-Midwife Supervision By 60 Days - Note: Superseded with DCA Waiver 20-67
• DCA Waiver DCA-20-27 Waiver Extending DCA Waiver DCA-20-01 Continuing Education - Note: Superseded with DCA Waiver 20-53
• DCA Waiver DCA-20-24 Extending Orders Relating to Physician Assistants, Nurse Practitioners and Nurse-Midwife Supervision By 60 Days - Note: Superseded with DCA Waiver 20-44
• DCA Waiver DCA-02-04 Physician Assistant Supervision Requirements - Note: Superseded with DCA Waiver 20-24
• Guidance on Physician Assistant Supervision Requirements Waiver Under DCA Waiver-02-04
• DCA Waiver DCA-20-02 Reinstatement of Licensure - Note: Superseded with DCA Waiver 20-57
• Controlled Substance Course Certificates
  Effective June 1st the Board will not accept certificates of completion from providers not listed on our website for the controlled substance education course
• Beginning Monday, June 15, 2020, the Physician Assistant Board office will be open to the public Monday through Friday from 8:00 a.m. to 5:00 p.m.
• NEW: Effective April 23, 2020, the Board’s new address is 2005 Evergreen Street, Suite 2250, Sacramento, CA 95815.
• EMSA Information for California and out-of-state health care providers regarding Coronavirus Disease 2019 (COVID-19)
• CDPH What You Need To Know: Novel Coronavirus 2019 (COVID-19)
• COVID-19 Updates
• Department of Health Care Services
• SB 697
  
  Implementation of SB 697, effective January 1, 2020, amends the California Physician Assistant Practice Act. To view the California Physician Assistant Practice Act visit California Legislative Information. Submit questions regarding amendments by emailing the PA Board.
  
  Information Bulletin - SB 697 Frequently Asked Questions
• AB 149 (Cooper) Transition Period for Prescription Form Requirements Effective March 11, 2019
• Statewide Prescription Opioid Misuse and Overdose Prevention